本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tempest Therapeutics Inc.

10.03
-0.4700-4.48%
盘后10.00-0.0300-0.30%17:00 EDT
成交量:2.46万
成交额:24.80万
市值:4,453.48万
市盈率:-0.51
高:10.35
开:10.33
低:9.90
收:10.50
52周最高:20.67
52周最低:5.35
股本:444.02万
流通股本:416.38万
量比:0.40
换手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-19.4955
每股收益(LYR):-19.4955
净资产收益率:-322.57%
总资产收益率:-81.34%
市净率:4.55
市盈率(LYR):-0.51

数据加载中...

2021/07/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/07

重要事件披露

8-K - Current report
2021/07/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/01

重要事件披露

8-K/A [Amend] - Current report
2021/06/28

重要事件披露

8-K - Current report
2021/06/23

重要事件披露

8-K - Current report
2021/06/11

企业合并公告

425 - Prospectuses and communications, business combinations
2021/06/11

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/29

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/29

企业合并公告

425 - Prospectuses and communications, business combinations
2021/03/29

重要事件披露

8-K - Current report
2021/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals